Read by QxMD icon Read


Sheshagiri Rao Damera, Ramachandra Barik, Akula Siva Prasad
The angioplasty of chronic total aortoiliac occlusion using transfemoral is controversial. From March 2014 to December 2015, four consecutive patients (4 males; mean age 58.2±6.8 years; age of range 51-65 years) underwent angioplasty and stenting of TASC-D occlusion. In all the cases, we failed to cross from femoral approach. On switching over to left brachial access, angioplasty was done successfully in all. There was no procedural site complication or clinical evidence cerebral thromboembolism. Self-expandable stents were implanted in all with adequate pre and post dilation...
September 2016: Indian Heart Journal
J-S Doly, E Lorian, I Desormais, J Constans, A Bura Rivière, P Lacroix
OBJECTIVES: To assess the prevalence and the association between aspirin resistance in critical limb ischemia patients using the VerifyNow(®) bed-side platelet test, and occurrence of cardiovascular morbidity and/or death at one year. MATERIALS AND METHODS: National multicenter prospective observational study related to COPART II centers. From 2010 through 2014, 64 subjects hospitalized for critical limb ischemia and already treated by aspirin before the VerifyNow(®) test were included...
October 13, 2016: Journal des Maladies Vasculaires
Erwin E Argueta, Alvaro Rosales, Jose A Suarez
OBJECTIVES: To describe our single center experience with the use of laser endartherectomy assisted balloon angioplasty in popliteal and infrapopliteal arterial disease. BACKGROUND: Peripheral arterial disease (PAD) carries significant morbidity to patients. Some patients may have multiple comorbid conditions potentially limiting therapeutic options for PAD. Endovascular interventions are aimed at decreasing arterial disease symptoms, improve wound healing and ultimately limb salvage...
October 1, 2016: International Journal of Cardiology
Pasqualino Sirignano, Francesco Speziale, Laura Capoccia, Danilo Menna, Wassim Mansour, Nunzio Montelione, Francesco Setacci, Giuseppe Galzerano, Carlo Setacci
BACKGROUND: To evaluate the impact of iliac artery's diameters, tortuosity, and peripheral vascular patency on outcome of elective endovascular repair (EVAR) of abdominal aortic aneurysms (AAA) in 2 high volume vascular centers' experience. METHODS: A retrospective study was conducted on a prospectively collected database between 2010 and 2012. Anatomical features at pre-operative computed tomography (CTA) considered as potentially influencing outcomes were: iliac diameters, tortuosity (expressed as a ratio), and calcifications, bilateral internal iliac artery (IIA) patency, and presence of Trans-Atlantic Inter-Societies Consensus (TASC) II C/D femoro-popliteal occlusive disease (PAD)...
September 16, 2016: Journal of Cardiovascular Surgery
Walter Dorigo, Gabriele Piffaretti, Filippo Benedetto, Antonino Tarallo, Patrizio Castelli, Francesco Spinelli, Aaron Fargion, Carlo Pratesi
OBJECTIVE: The aim of this study was to retrospectively compare early and late results of aortobifemoral bypass and endovascular recanalization with the kissing stent technique in the management of TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions in the aortoiliac district in a multicenter study. METHODS: From January 2006 to December 2013, 210 open and endovascular interventions for TASC II class C and D aortoiliac obstructive lesions were performed at three Italian teaching hospitals...
September 12, 2016: Journal of Vascular Surgery
S A Papoian, A A Shchegolev, D G Gromov, B A Kvitsaridze, M Iu Sazonov, A V Gavrilenko
Presented herein are the results of endovascular interventions carried out in patients with occlusive lesions of the terminal portion of the aorta and iliac arteries (types C and D according to the TASC II classification). The study comprised a total of 45 subjects with type C and D lesions. The technical success rate in the group of patients with type C lesions amounted to 100% and in the group of those with type D lesions to 92.8%. One-year primary patency of iliac arteries after the endovascular intervention was assessed in 40 patients and amounted to 100% for type C lesions and to 92...
2016: Angiologii︠a︡ i Sosudistai︠a︡ Khirurgii︠a︡, Angiology and Vascular Surgery
Kenji Suzuki, Mitsuyoshi Takahara, Yoshiaki Shintani, Akiko Tanaka, Yoshimitsu Soga, Terutoshi Yamaoka, Atsushi Tosaka, Shinya Sasaki, Daizo Kawasaki, Taketsugu Tsuchiya, Amane Kozuki, Osamu Iida
PURPOSE: To compare primary patency between MISAGO (Terumo Corporation, Tokyo, Japan) and S.M.A.R.T. CONTROL (Cordis Corporation, Miami Lakes, Florida), second-generation and first-generation nitinol stents, in femoropopliteal lesions. MATERIALS AND METHODS: This multicenter, retrospective study included 240 cases with MISAGO stent implantation and 1,265 cases with S.M.A.R.T. stent implantation. The S.M.A.R.T. group had more Trans-Atlantic Inter-Society of Consensus (TASC) II class C/D lesions (53% vs 41%, P = ...
August 24, 2016: Journal of Vascular and Interventional Radiology: JVIR
Andrew K Roy, Phillipe Garot, Yves Louvard, Antoinette Neylon, Marco Spaziano, Fadi J Sawaya, Leticia Fernandez, Yann Roux, Raphael Blanc, Michel Piotin, Stephane Champagne, Oscar Tavolaro, Hakim Benamer, Thomas Hovasse, Bernard Chevalier, Thierry Lefèvre, Thierry Unterseeh
PURPOSE: To compare the procedure and safety outcomes of the transradial approach (TRA) with the femoral approach (FA) for treating aortoiliac and femoropopliteal stenoses and occlusions. METHODS: A single-center retrospective study was conducted involving 188 patients (mean age 66.4±10.8 years; 116 men) with lower limb claudication or critical limb ischemia who underwent aortoiliac (131, 62.4%) or femoropopliteal (79, 37.6%) interventions on 210 lesions over a 3-year period...
August 24, 2016: Journal of Endovascular Therapy
Kenneth Tran, Brant W Ullery, Marcus R Kret, Jason T Lee
BACKGROUND: The aim of this study was to evaluate the performance and predictors of stent failure of paclitaxel drug-eluting stents for the treatment of femoropopliteal disease. METHODS: A retrospective review of clinical and angiographic data was performed for patients treated for femoropopliteal disease with the Zilver PTX (Cook Medical, Bloomington, IN) stent by a single operator between 2012 and 2015 at a tertiary referral center. Clinical grading was determined by both Rutherford classification and the Society for Vascular Surgery's Wound, Ischemia, and Foot Infection (WIFi) scoring system, and lesions were classified anatomically by the TransAtlantic Intersociety Consensus (TASC) II criteria...
August 20, 2016: Annals of Vascular Surgery
Robert Ward, Joie Dunn, Leonardo Clavijo, David Shavelle, Vincent Rowe, Karen Woo
OBJECTIVES: Patients presenting to a public hospital with critical limb ischemia (CLI) typically have advanced disease with significant co-morbidities. The purpose of this study was to assess the influence of revascularization on one year amputation rate of CLI patients presenting to Los Angeles County USC Medical Center, classified according to the SVS WIfI. METHODS: A retrospective review of patients who presented to a public hospital with CLI from February 2010 to July 2014 was performed...
August 18, 2016: Annals of Vascular Surgery
Junya Matsumi, Kazuki Tobita, Koki Shishido, Shingo Mizuno, Futoshi Yamanaka, Masato Murakami, Yutaka Tanaka, Saeko Takahashi, Takeshi Akasaka, Shigeru Saito
OBJECTIVES: This study aimed to determine the long-term outcomes of SMART stent implantation for femoro-popliteal (FP) lesions. BACKGROUND: The long-term results of SMART stent implantation for FP lesions remained unknown. METHODS: We studied 319 limbs in 269 patients (mean age: 73.2 ± 7.7 years) who underwent SMART stent implantation for FP lesions (mean treated-lesion length: 118.5 ± 81.0 mm) from 2004 to 2014, retrospectively...
August 18, 2016: Catheterization and Cardiovascular Interventions
Karen M Bussard, Lysette Mutkus, Kristina Stumpf, Candelaria Gomez-Manzano, Frank C Marini
The tumor microenvironment is a heterogeneous population of cells consisting of the tumor bulk plus supporting cells. It is becoming increasingly evident that these supporting cells are recruited by cancer cells from nearby endogenous host stroma and promote events such as tumor angiogenesis, proliferation, invasion, and metastasis, as well as mediate mechanisms of therapeutic resistance. In addition, recruited stromal cells range in type and include vascular endothelial cells, pericytes, adipocytes, fibroblasts, and bone-marrow mesenchymal stromal cells...
2016: Breast Cancer Research: BCR
Won Yu Kang, Umberto Campia, Romain J Didier, Sarkis Kiramijyan, Edward Koifman, Smita I Negi, Michael J Lipinski, Nevin C Baker, Ricardo O Escarcega, Rebecca Torguson, Ron Waksman, Nelson L Bernardo
BACKGROUND: Clinical trial data show overall favorable outcomes of paclitaxel-eluting stents for treatment of femoro-popliteal (FP) occlusive disease. However, external validity of trial results may be restricted to less complex FP lesions, and limited data on outcomes of paclitaxel-eluting stents in real world practice have been published. METHODS: This is a retrospective analysis of data of all patients who received Zilver® PTX® for FP lesion from February 2013 to October 2014 at our center...
September 2016: Cardiovascular Revascularization Medicine: Including Molecular Interventions
Cynthia de Almeida Mendes, Marcelo Passos Teivelis, Sergio Kuzniec, Juliana Maria Fukuda, Nelson Wolosker
OBJECTIVE: To analyze the results of ten angioplasties of TASC C and D femoropopliteal lesions using CO2 as primary contrast in patients with no formal contraindication to iodine, aiming to decrease allergic reactions and potential nephrotoxicity in high-risk patients. METHODS: We describe the results of ten angioplasties of TASC C and D femoropopliteal lesions using CO2 as primary contrast in patients with high risk for open revascularization and no formal contraindication to iodine...
April 2016: Einstein
Jan Bontinck, Peter Goverde, Herman Schroë, Jeroen Hendriks, Lieven Maene, Frank Vermassen
OBJECTIVE: Bioresorbable stents are an emerging technology in the endovascular treatment of femoropopliteal lesions. They address the issue of leaving permanent stents in the treated arterial segment that are only temporarily needed to treat dissection or recoil. The REMEDY stent (Kyoto Medical Planning Co, Kyoto, Japan) was the first commercially available biodegradable scaffold for peripheral use. We evaluated its performance and safety in the treatment of short femoropopliteal stenosis or occlusion...
July 22, 2016: Journal of Vascular Surgery
Daijirou Akamatsu, Hitoshi Goto, Takashi Kamei, Shigehito Miyagi, Ken Tsuchida, Keiichiro Kawamura, Yuta Tajima, Michihisa Umetsu, Tetsuo Watanabe, Noriaki Ohuchi
BACKGROUND: In multilevel arterial disease, whether complete revascularization or staged runoff repair should be performed remains controversial. The aim of this study was to evaluate the efficacy of iliac inflow repair and to identify clinical conditions that are associated with the need for runoff repair in concomitant iliac and superficial femoral artery (SFA) occlusive disease. METHODS: Patients undergoing inflow repair for complicated flow-limiting iliac lesions with diffuse SFA disease between 2007 and 2013 were retrospectively reviewed...
July 19, 2016: Asian Journal of Surgery
Timothy W I Clark, Micah M Watts, Tak W Kwan
PURPOSE: To report preliminary experience with femoropopliteal revascularization using a completely transpedal/transtibial approach. MATERIALS AND METHODS: Three patients with Rutherford 3-4 disease underwent revascularization of TASC C/D lesions using a pedal/tibial artery as the only site of arterial access. RESULTS: One patient with a chronic superficial femoral artery occlusion had continuity achieved to the common femoral artery using a dedicated reentry device and stenting; in a second patient, an occluded popliteal artery stent was successfully revised with an endograft; and in a third patient with morbid obesity, a chronic SFA occlusion was successfully stented...
July 20, 2016: Cardiovascular and Interventional Radiology
Marcus Vinícius Martins Cury, Francisco Cardoso Brochado-Neto, Marcelo Fernando Matielo, Rafael de Athayde Soares, Anna Karina Paiva Sarpe, Roberto Sacilotto
BACKGROUND: The aim of this study was to determine the outcomes of primary bypass graft surgery (BGS) compared to BGS after failed angioplasty (PTA). PATIENTS AND METHODS: Between January 2007 and January 2014, we performed 136 BGSs exclusively for the treatment of critical limb ischaemia. Two cohorts were identified: 1) primary BGS (n = 102; group I), and 2) BGS after prior PTA (n = 34; group II). Data were analysed retrospectively and the primary endpoints were the rates of secondary patency, amputation-free survival, freedom from major adverse outcomes (graft occlusion, amputation, or death), and overall survival, which were assessed with the Kaplan-Meier method...
2016: VASA. Zeitschrift Für Gefässkrankheiten
Francis G Fowkes, Rachel Forster, Carol E Levin, Nadraj G Naidoo, Ambuj Roy, Chang Shu, John Spertus, Kun Fang, Luis Bechara-Zamudio, Mariella Catalano, Adriana Visona, Sigrid Nikol, John P Fletcher, Michael R Jaff, William R Hiatt, Lars Norgren
Lower extremity peripheral artery disease (PAD) is increasing in prevalence in low- and middle-income countries creating a large health care burden. Clinical management may require substantial resources but little consideration has been given to which treatments are appropriate for less advantaged countries. The aim of this review was to systematically appraise published data on the costs and effectiveness of PAD treatments used commonly in high-income countries, and for an international consensus panel to review that information and propose a hierarchy of treatments relevant to low- and middle-income countries...
July 7, 2016: International Angiology: a Journal of the International Union of Angiology
Juho M Jalkanen, Jan-Erik Wickström, Maarit Venermo, Harri H Hakovirta
The results of amputation free survival (AFS) of a cohort of 887 caucasian patients is shown. The data is based on further analyses of data presented in Jalkanen et al. (2016) [1]. The 36-month amputation free survival of patients divided in new crural vessel disease classification (Crural Index), aortoiliac TASC II classification, femoropopliteal TASC II classification and most severe segment is presented. Also, in depth demographic data is presented for each Crural Index group Jalkanen et al., 2016 [1].
September 2016: Data in Brief
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"